Wednesday, 15 Aug 2018

You are here

RheumNow Week in Review – 21 October 2016

Dr. Cush Reviews Highlights from the past week on Register to receive free daily rheumatology news written by rheumatologists for rheumatologists. Download the podcast at

  1. The Japanese SURPRISE study looked 223 RA MTX-IR patients Rx with either TCZ+MTX or TCZ: earlier DAS28 Responses & less Xray damage seen with add-on vs switch therapy.
  2. Psoriasis patients failing TNF inhibitor shows secondary failure more likely than primary failure to respond to a 2nd TNFi.
  3. UK prevalence study shows only one-third of ankylosing spondylitis is treated by rheumatologists.
  4. 2 studies of 169 RA patients shows that US guided Bx for synovial tissue shown to be 82-93% success and with very rare AE (ie, hemarthrosis)
  5. Study of 104 early spondyloarthritis pts shows SI xrays readings maybe unreliable, even with experienced radiologists
  6. Postural abnormalities and worse spinal metrics in Ankylosing spondylitis is associated with significant balance issues.
  7. Surgical patients with Sleep Apnea at higher risk of atrial fibrillation and venous thromboembolism (preliminary results)
  8. Pregabalin/Lyrica shown to be effective in treating abdominal pain associated with irritable bowel syndrome.
  9. TNF inhibitor use in 16 renal transplant patients with good efficacy, no decline in GFR after 2yrs of followup, but 50% had Serious infections,
  10. Just presented: the Nor-Switch Study shows it's safe to switch to a biosimilar
  11. Inflectra Biosimilar estimated to ship in Late November 2016 
  12. Low-Molecular Weight Heparin Does Not Reduce Pregnancy Complications
  13. Review of Herpes Zoster with Immunosuppression and Autoimmune Disease
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.

The RheumNow Week in Review – Lupus in the News (7.27.18)

Dr. Jack Cush reviews the news and journal reports from the past week on

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on in the past week.